Drug Approval | March 21, 2022
Zydus receives PAS approval for Mycophenolate Mofetil
The drug is indicated for use in combination with other drugs
The drug is indicated for use in combination with other drugs
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
The facility will produce 150 million vaccine doses per year
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
Subscribe To Our Newsletter & Stay Updated
